Radiologist cites 'inattentional blindness' after missing signs of metastasis in patient

A woman in New Zealand is now battling advanced cancer after signs of metastasis eluded the eyes of a radiologist.  

In 2022 a woman, who was not named in official reports, was diagnosed with terminal cancer shortly after noticing a lump in her left breast. Not only was the lump deemed malignant, but her cancer also had spread into her lymph nodes and liver. 

This news came as a surprise, as a year earlier she had gotten a clean report from a radiologist interpreting a CT she had undergone to make sure her previous cancer—melanoma that had spread but was successfully treated with immunotherapy—had not recurred. The radiologist reading that exam made no note of any suspicious findings, but an investigation later revealed that the scan, which was of her chest, abdomen and pelvis, showed clear evidence of axillary lymphadenopathy. 

The woman also had an MRI of her shoulder in 2021. That scan, interpreted by a different radiologist, also had abnormal lymph nodes that were not reported. 

The CT miss is being attributed to “inattentional blindness,” according to an official report from Deputy Health and Disability Commissioner Vanessa Caldwell. The radiologist involved explained that he was looking for typical pathways the woman’s previous cancer would have spread on the right side of her body. 

“Usually it would ascend along the lymph nodes on the right side of the lower limb, then into the abdomen. I note the concept of ‘inattentional blindness’ in this regard,” he said during the investigation. “The presentation of breast cancer was not what I was looking for.” 

Investigators deemed the finding as “possibly/definitely significant,” noting that it should have been reported. Had it been, it could have prompted an earlier mammogram and, thus, an earlier diagnosis. 

The radiologist has since made verbal and written apologies to the patient, in addition to adjusting how he conducts his reads. He has adapted his structured report “to include expanding the review areas outside those of an expected tumor biology.” He also had his interpretations reviewed by a peer radiologist for several months after the incident. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup